Literature DB >> 15223996

Should pancreas imaging be recommanded in patients over 50 years when diabetes is discovered because of acute symptoms?

J Damiano1, L Bordier, J P Le Berre, J Margery, O Dupuy, H Mayaudon, B Bauduceau.   

Abstract

The relationship between diabetes mellitus and cancer of the pancreas is complex and incompletely understood. Nevertheless, it is generally agreed that new-onset diabetes in a patient over 50 Years old is a classical indication of pancreatic cancer. But there is no official directive in France that a scan should routinely be performed in such cases. We have studied 115 patients aged over 50 who were hospitalized for new-onset diabetes (fewer than 30 days) whose instability required insulin treatment. Routine imaging revealed abdominal disorders in 14 patients, 6 (5.2%) of whom were suffering from pancreatic adenocarcinomas. No clinical indication or laboratory test, apart from an unusually severe anorexia, suggested the discovered disorders. We therefore routinely carry out a pancreas scan, preferably by MRI, on all patients over 50 Years old presenting with new-onset diabetes, even if there are not clinical or laboratory indications of cancer. This is the only way in which small pancreatic cancers can be detected, thus providing the best hopes for successful treatment. Unfortunately, too often, this approach also detects only tumors that are already well developed. However, nowadays, it is not conceivable for a clinical team to discharge a patient from hospital with such a serious disease undiagnosed.

Entities:  

Mesh:

Year:  2004        PMID: 15223996     DOI: 10.1016/s1262-3636(07)70111-8

Source DB:  PubMed          Journal:  Diabetes Metab        ISSN: 1262-3636            Impact factor:   6.041


  21 in total

Review 1.  Detecting early pancreatic cancer: problems and prospects.

Authors:  Suresh T Chari
Journal:  Semin Oncol       Date:  2007-08       Impact factor: 4.929

2.  Does diabetes mellitus affect presentation, stage and survival in operable pancreatic cancer?

Authors:  Clement L K Chia; Anthea Y S Lee; Vishal G Shelat; Saleem Ahmed; Sameer P Junnarkar; Winston W L Woon; Jee-Keem Low
Journal:  Hepatobiliary Surg Nutr       Date:  2016-02       Impact factor: 7.293

Review 3.  Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer.

Authors:  Phil A Hart; Melena D Bellin; Dana K Andersen; David Bradley; Zobeida Cruz-Monserrate; Christopher E Forsmark; Mark O Goodarzi; Aida Habtezion; Murray Korc; Yogish C Kudva; Stephen J Pandol; Dhiraj Yadav; Suresh T Chari
Journal:  Lancet Gastroenterol Hepatol       Date:  2016-10-12

4.  Probability of pancreatic cancer following diabetes: a population-based study.

Authors:  Suresh T Chari; Cynthia L Leibson; Kari G Rabe; Jeanine Ransom; Mariza de Andrade; Gloria M Petersen
Journal:  Gastroenterology       Date:  2005-08       Impact factor: 22.682

5.  Weight loss precedes cancer-specific symptoms in pancreatic cancer-associated diabetes mellitus.

Authors:  Phil A Hart; Pratima Kamada; Kari G Rabe; Sunil Srinivasan; Ananda Basu; Gaurav Aggarwal; Suresh T Chari
Journal:  Pancreas       Date:  2011-07       Impact factor: 3.327

Review 6.  The early diagnosis of pancreatic cancer and diabetes: what's the relationship?

Authors:  Changsong Zhang; Guangshun Yang; Yang Ling; Guihua Chen; Tianbao Zhou
Journal:  J Gastrointest Oncol       Date:  2014-12

7.  Temporal association of changes in fasting blood glucose and body mass index with diagnosis of pancreatic cancer.

Authors:  Rahul Pannala; Cynthia L Leibson; Kari G Rabe; Lawrence J Timmons; Jeanine Ransom; Mariza de Andrade; Gloria M Petersen; Suresh T Chari
Journal:  Am J Gastroenterol       Date:  2009-06-09       Impact factor: 10.864

8.  Adrenomedullin is up-regulated in patients with pancreatic cancer and causes insulin resistance in β cells and mice.

Authors:  Gaurav Aggarwal; Vijaya Ramachandran; Naureen Javeed; Thiruvengadam Arumugam; Shamit Dutta; George G Klee; Eric W Klee; Thomas C Smyrk; William Bamlet; Jing Jing Han; Natalia B Rumie Vittar; Mariza de Andrade; Debabrata Mukhopadhyay; Gloria M Petersen; Martin E Fernandez-Zapico; Craig D Logsdon; Suresh T Chari
Journal:  Gastroenterology       Date:  2012-09-06       Impact factor: 22.682

Review 9.  Diabetes and pancreatic cancer.

Authors:  T Muniraj; S T Chari
Journal:  Minerva Gastroenterol Dietol       Date:  2012-12

10.  Pancreatic cancer-associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer.

Authors:  Suresh T Chari; Cynthia L Leibson; Kari G Rabe; Lawrence J Timmons; Jeanine Ransom; Mariza de Andrade; Gloria M Petersen
Journal:  Gastroenterology       Date:  2007-10-26       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.